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Background: Acute myocardial infarction (AMI) is often present in old populations and rare in young people. Its
incidence significantly increased recent years. The mechanism and disease course of AMI in young people are
probably different from that in old population. The aim of this study was to analyze clinical risk factors of STEMI in
young patients.
Methods: Data was collected from consecutive patients ≤ 44 years of age (young; n = 86) and 60–74 years of age
(old; n = 65) diagnosed with STEMI, and 79 young age-matched patients without coronary artery disease (CAD),
hospitalized between January 2009 and June 2013.
Results: The young STEMI group had a significantly higher proportion of males (88.37 vs. 53.16%; P < 0.01), smokers
(82.56 vs. 49.37%; P < 0.01) and patients with a family history of early CAD (54.65 vs. 32.91%; P < 0.05) than age-matched
controls. Young STEMI patients also had significantly higher levels of fasting blood sugar (6.39 vs. 5.25 mmol/L;
P < 0.001), glycated hemoglobin (HbA1c) (6.26 vs. 5.45%; P < 0.05), total cholesterol (5.14 vs. 4.65 mmol/L, P < 0.05), and
fibrinogen (Fib) (3.39 vs. 2.87; P < 0.01). Compared with the old STEMI group, young STEMI patients had significantly
higher proportions of males (88.37 vs. 63.08%; P < 0.01) smokers (82.56 vs. 41.54%; P < 0.01), and those with a family
history of early CAD (54.65 vs. 18.46%; P < 0.01). Young STEMI patients also lower Fib (3.39 vs. 3.88 g/L; P < 0.01), less
frequent occurrence of angina pectoris before STEMI (13.95 vs. 29.23%; P < 0.05) compared with the old STEMI group.
Logistic regression analysis indicated that male sex (OR = 5.891), smoking (OR = 3.500), family history of early CAD
(OR = 3.194), Fib (OR = 2.414) and HbA1c (OR = 1.515) are associated with STEMI in young patients.
Conclusion: In addition to previously recognized risk factors (male sex, smoking and family history of early CAD), Fib
and HbA1c are associated with STEMI in individuals ≤ 44 years of age without antecedent angina pectoris.
Keywords: Antecedent angina pectoris, Fibrinogen, Glycated hemoglobin, Risk factors, ST-segment elevation
myocardial infarction, Young patientsBackground
Acute myocardial infarction (AMI) is a major cause of
death worldwide. AMI is less frequent in adults younger
than 45 years of age than in elderly adults [1,2], but is of
increasing clinical interest in young adults because of
the potential of premature death and long-term disability
[3]. The incidence of AMI in young people was as low
as 2–6% [1,2], but has recently begun to rise. The pro-
tection offered by young age is countered by increased
prevalence of risk factors for coronary artery disease* Correspondence: litong3zx@sina.com
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unless otherwise stated.(CAD), such as impaired glucose tolerance and obesity,
in adolescence [4]. Ignorance of CAD combined with a
false sense of security likely prevents younger individuals
from seeking medical advice. Early recognition and risk
factor modification in this population is of key import-
ance [5].
The mechanism and disease course of AMI in young pa-
tients are likely different from those in an older population,
and knowing of theses differences may help to prevent the
disease and improve the prognosis [6]. However, there are
few studies investigating risk factor profiles and patterns of
coronary artery involvement in ST-segment elevation myo-
cardial infarction (STEMI) in younger individuals. Thisl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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This study was approved by ethics committee of The
Third Central Hospital of Tian Jin. The study protocols
comply with the ethical guidelines of the Declaration of
Helsinki. All subjects provided informed consent.
Subjects
This was a retrospective study of 86 consecutive young
patients (18–44 years of age) with STEMI selected from
a total of 2460 AMI patients enrolled between January
2009 and June 2013 at The Third Central hospital of
Tianjin. A group of 79 young adults of the same age
range who made consecutive visits to the hospital during
the same period, were enrolled as controls. Coronary
heart disease was excluded in this group by coronary
angiography. An additional group of 65 consecutive old
patients (60–74 years of age) with STEMI were included
for comparison.
Inclusion criteria
Patients included in the study were diagnosed with
STEMI, defined by the typical rise and fall of cardiac
markers of myocardial necrosis with at least one of the
following [7]: i) symptoms of ischemia; ii) echocardio-
gram changes indicative of new ischemia (≥ 0.1 mV in
two or more standard leads, ≥ 0.2 mV in two or more
contiguous pre-cordial leads, or a new left bundle
branch block); iii) 12 h after symptoms, levels of creating
kinase and its isoform (CKMB) were twice the normal
upper limit or a troponin level was increased to the
standard of MI (according to the normal local laboratory
value). All patients had complete medical records and
had undergone coronary angiography.
Exclusion criteria
Patients with the following conditions were excluded:
congenital heart disease, cardiomyopathy, myocarditis,
Takayasu’s arteritis or vascular dysplasia; coronary artery
embolism; AMI secondary to aortic dissection, severe
aorta valve stenosis, myocardial hypertrophy, and history
of AMI without evidence from angiography showing
narrowing of the coronary arteries.
Data collection
Demographic and baseline data were collected by ques-
tionnaire at patient interviews and by review of medical
records. Medical records were analyzed for the patients’
CAD risk factor profiles. Baseline data included gender,
age, body mass index, history of smoking or drinking,family history of CAD, medical history of hypertension,
type II diabetes mellitus, cranial vascular accidents, sys-
tolic and diastolic pressure, and the presence of other dis-
eases. A TBA-120FR auto-biochemical analyzer (Toshiba,
Japan) and Sysmex kx-21 hematology analyzer (Sysmex,
Japan) were used to measure fasting blood sugar, glycated
hemoglobin (HbA1c), creatine kinase and CKMB, tropo-
nin I (normal range 0.05–0.40 ng/mL), triglycerides (TG),
total cholesterol (TC), non-high-density lipoprotein
cholesterol (NHDL-C), HDL-C, and fibrinogen (Fib) in
the morning after hospital admission, following an
overnight fast.
Criteria for other conditions
Hypertension was defined as a systolic pressure ≥
140 mmHg and/or a diastolic pressure ≥ 90 mmHg [8]; a
history of hypertension was noted in patients using anti-
hypertension medications. Type II diabetes was noted in
patients who met the 1999 WHO diagnosis criteria [9].
Unstable angina pectoris (AP) before AMI included ini-
tial AP on effort, exacerbation of effort AP, spontaneous
AP, mixed AP, variant angina, and angina that occurred
within one month of AMI, each episode lasting 2–
20 min [10]. Smoking was defined as smoking for six
months or longer, and a smoking index was calculated
as the number of daily cigarettes × years of smoking [11].
A family history of early CAD was recorded in patients
where it was first diagnosed in the father at ≤ 55 or the
mother at ≤ 65 years of age.
Coronary angiography
Due to delays for hospital admittance in some patients, cor-
onary angiography was performed within one month after
STEMI via the radial artery using a multifunction catheter
or via the femoral artery using the Judkins method. The re-
sults were interpreted by two experienced physicians.
Statistical analysis
SPSS 17.0 software (SPSS Inc., Chicago, IL, USA) was
used for all data analysis. Normally distributed numeric
data are presented as means ± standard deviation and in-
tergroup comparisons were conducted with a Student’s
t-test. Non-normally distributed numeric data are pre-
sented as medians and quartiles (M [Q1, Q3]) and inter-
group comparisons were conducted with the Mann–
Whitney U test. Categorical data were tested with the χ2
test. A logistic regression model was used to identify risk
factors of STEMI in young patients. All tests were two
sided and P < 0.05 was regarded as significant.
Results
Comparison between young STEMI and control patients
Baseline clinical and laboratory test data in the young
STEMI and young control groups are summarized in
Table 2 Comparison of young and old STEMI groups
Variable Young Old P
(n = 86) (n = 65)
Age, y 40.00 (23, 44) 69.15 (63,74) < 0.001
Male, n (%) 76 (88.37) 41 (63.08) 0.001
BMI, kg/m2 27.96 ± 2.80 26.18 ± 2.30 0.346
Systolic pressure, mmHg 133.59 (90, 200) 131.09 (96,180) 0.885
Diastolic pressure, mmHg 81.03 (50, 124) 73.20 (46, 120) 0.005
Pulse pressure, mmHg 52.67 (25, 90) 57.89 (30, 100) 0.030
Fasting blood sugar
(mmol/L)
6.39 (3.76, 18.00) 6.02 (3.61, 12.00) 0.682
HbA1C (%) 6.26 ± 1.69 6.29 ± 1.47 0.458
CK (U/L) 1950.28 ± 1639.52 1691.35 ± 1411.02 0.533
CKMB (U/L) 163.99 ± 127.38 189.14 ± 173.26 0.066
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family history of early CAD, and the smoking index
values in the STEMI group were significantly higher than
those in the control group (Ps < 0.05). STEMI patients had
significantly higher fasting blood sugar, HbA1c, TC,
NHDL-C and Fib levels than controls (Ps < 0.05). There
were no differences between the two groups in age,
blood pressure, TG, HDL-C, hypertension, type II dia-
betes, cerebrovascular diseases, or drinking.
Comparison between young and old STEMI patients
Baseline clinical and laboratory test data in the young and
old STEMI groups are summarized in Table 2. The gender,
diastolic pressure, pulse pressure, smoking, smoking index
values, and family history of early CAD were significantly




(n = 86) (n = 79)
Age, y 40.00 (23, 44) 39.94 (27, 44) 0.317
Male, n (%) 76 (88.37) 42 (53.16) <0.001
BMI (kg/m2) 27.96 ± 2.80 25.16 ± 3.15 0.127
Systolic pressure (mmHg) 133.59 (90, 200) 134.82 (100, 190) 0.629
Diastolic pressure (mmHg) 81.03 (50, 124) 83.37 (60, 140) 0.957
Pulse pressure (mmHg) 52.67 (25, 90) 51.71 (30, 90) 0.608
Fasting blood sugar
(mmol/L)
6.39 (3.76, 18.00) 5.25 (3.25, 12.35) <0.001
HbA1C (%) 6.26 ± 1.69 5.45 ± 1.12 0.018
CK (U/L) 1950.28 ± 1639.52 81.15 ± 44.60 <0.001
CKMB (U/L) 163.99 ± 127.38 14.77 ± 13.35 <0.001
TNI (ng/mL) 3.08 (0.11, 30) 0.07 (0.05, 0.3) <0.001
TG (mmol/L) 2.37 ± 2.48 2.25 ± 1.26 0.201
TC (mmol/L) 5.14 ± 1.39 4.65 ± 0.87 0.002
NHDL-C (mmol/L) 4.06 ± 1.35 3.53 ± 0.87 0.002
HDL-C (mmol/L) 1.07 ± 0.27 1.12 ± 0.26 0.856
Fib (g/L) 3.39 (1.90, 7.52) 2.87 (1.78, 5.30) <0.001
Hypertension, n (%) 41 (47.67) 35 (44.30) 0.755
Type II diabetes, n (%) 18 (20.93) 17 (21.52) 1.000
Cerebrovascular diseases,
n (%)
6 (6.98) 2 (2.53) 0.281
Alcohol drinking, n (%) 25 (29.07) 19 (24.05) 0.486
Smoking, n (%) 71 (82.56) 39 (49.37) <0.001
Smoking index 329.53 (0, 1200) 179.49 (0, 900) <0.001
Family history of
early CAD, n (%)
47 (54.65) 26 (32.91) 0.007
Abbreviations: BMI body mass index, CAD coronary artery disease, CK creatine
kinase, CKMB isoform of CK, Fib fibrinogen, HbA1c glycated hemoglobin, HDL-C
high-density lipoprotein cholesterol, MI myocardial infarction, NHDL-C non-
HDL-C, TC total cholesterol, TG triglyceride, TNI troponin I, STEMI ST-segment
elevation myocardial infarction.
Note: Data are expressed as mean ± standard deviation or medians (Q1, Q3).
TNI (ng/mL) 3.08 (0.11, 30) 3.40 (0.17, 30) 0.664
TG (mmol/L) 2.37 ± 2.48 1.29 ± 0.48 0.001
TC (mmol/L) 5.14 ± 1.39 4.74 ± 0.85 0.005
NHDL-C (mmol/L) 4.06 ± 1.35 3.60 ± 0.76 0.003
HDL-C (mmol/L) 1.07 ± 0.27 1.14 ± 0.24 0.760
Fib (g/L) 3.39 (1.90, 7.52) 3.88 (2.06, 10.94) < 0.001
Hypertension, n (%) 41 (47.67) 35 (53.85) 0.512
Type II diabetes, n (%) 18 (20.93) 21 (32.30) 0.135
Cerebrovascular diseases,
n (%)
6 (6.98) 18 (27.69) < 0.001
Alcohol drinking, n (%) 25 (29.07) 7 (10.77) 0.008
Smoking, n (%) 71 (82.56%) 27 (41.54) < 0.001
Smoking index 329.53 (0, 1200) 263.54 (0, 2400) < 0.001
Family history of early
CAD, n (%)
47 (54.65) 12 (18.46) < 0.001
Angina pectoris before
MI, n (%)
12 (13.95) 19 (29.23) 0.026
Abbreviations: BMI body mass index, CAD coronary artery disease, CK creatine
kinase, CKMB isoform of CK, Fib fibrinogen, HbA1c glycated hemoglobin, HDL-C
high-density lipoprotein cholesterol, MI myocardial infarction, NHDL-C non-
HDL-C, STEMI ST-segment elevation myocardial infarction, TC total cholesterol,
TG triglyceride, TNI troponin I.
Note: Data are expressed as mean ± standard deviation or medians (Q1, Q3).young group were less likely to have cerebrovascular dis-
eases or experience AP before STEMI than the older pa-
tients. TG, TC, and NHDL-C levels were higher, and serum
Fib was lower, in young compared with old STEMI patients
(Ps < 0.05). Smoking and imbalance of lipid metabolism
were more common in young STEMI patients than in old
patients (Ps < 0.05).
Risk factors of STEMI
Using STEMI as a dependent variable, independent risk
factors among young patients were determined as those
with a P < 0.25 in Student’s t-tests, including gender,
smoking history, smoking index, family history of early
CAD, and levels of blood sugar, HbA1c, TC, NHDL-C,
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The analysis revealed that gender, smoking, family his-
tory of CAD, Fib, and HbA1c levels were independent
risk factors for STEMI in young individuals (Ps < 0.05)
(Table 3).
Discussion
The lifestyles of young people, characterized by high
work stress, fast pace, overwork, smoking, drinking alco-
hol, and overeating, likely cause disturbances in the in-
ternal environment, such as coronary atherosclerosis,
that increase the incidence of AMI [12]. Atherosclerosis,
which is affected by many factors, may cause coronary
spasms or broken plaque in coronary arteries resulting
in acute blockage [13]. In this study, we found that
STEMI tended to occur suddenly in young patients and
in those without a history of AP.
Conventional risk factors for STEMI include male sex,
smoking, and a family history of early CAD [14]. In ac-
cordance with this and another study [15], we found that
male sex was an important risk factor for STEMI in
young patients. Androgen was shown to negatively cor-
relate with the incidence of STEMI, and physiologic
levels can prevent atherosclerosis [16]. Androgen levels,
which peak at age 20–24 and then decline gradually, are
significantly reduced in atherosclerosis patients, and low
androgen levels can induce heart diseases and predict
AMI [17]. The unhealthy habits such as smoking, drink-
ing, and eating high-fat or high-purine diets may also in-
crease the risk of AMI in young men compared with
older male and young female populations. This may ex-
plain why the group of young STEMI patients included
a significantly higher proportion of males than the old
group.
A recent study published by Cases and Rate [18] found
that among 6892 STEMI who received percutaneous
coronary intervention, 46.4% were smokers, compared
with 20.5% in the general population. Studies in China
and other countries demonstrated that young AMI pa-
tients have smoking rates as high as 70–90% [5,19]. As
our data show, young STEMI patients are more likelyTable 3 Logistic regression analysis of STEMI risk factors
in young patients
Factors B value SE Wald OR 95% CI P
Male 1.7731 0.508 12.177 5.891 2.176–15.950 <0.001
Smoking history 1.253 0.473 7.016 3.500 1.385–8.842 0.008
Family history of
early CAD
1.161 0.409 8.059 3.194 1.433–7.122 0.005
Fib 0.881 0.288 9.366 2.414 1.373–4.245 0.002
HbA1c 0.415 0.165 6.370 1.515 1.097–2.091 0.012
Abbreviations: CAD coronary artery disease, CI confidence interval, Fib fibrinogen,
HbA1c glycated hemoglobin, OR odds ratio, SE standard error, STEMI ST-segment
elevation myocardial infarction.than older patients to be smokers. The risk of AMI de-
creases after smokers quit, and the benefit of quitting is
correlated with amount smoked [11]. Moreover, smoking
cessation can help prevent cardiovascular events, espe-
cially in young people [18].
The results of our study show that 58.33% of young
patients have a family history of early CAD, which is
higher than the 30–40% of young AMI patients reported
by Colkesen et al. [20]. Patients with a family history of
CAD have more severe disease progression than those
without a history [21], more lipid metabolism disorders,
and more likely to have insulin resistance and be obese,
possibly resulting from hereditary factors [22].
An important finding from our study is that levels of
HbA1c and Fib were independent risk factors for STEMI
in young patients. Fib is associated with vascular endo-
thelial injury, and enhances the coagulation of platelets
and increase in blood viscosity to induce thrombosis. Fib
level is significantly associated with coronary artery cal-
cification and sclerosis [23], and levels are significantly
higher in patients who die from coronary diseases than
in those who survive [24]. A study by Tatli et al. [25]
showed that Fib can predict the extent of coronary ar-
tery narrowing in young AMI patients. In this study, the
Fib levels were significantly higher in young STEMI pa-
tients compared with controls, and logistic regression
analysis indicated it was an independent risk factor of
STEMI, further confirming the role of coagulation disor-
ders in STEMI in the young population. Old STEMI pa-
tients also had higher Fib levels, suggesting that its effect
in this population is even more important.
Although diabetes is an important risk factor for cor-
onary disease, its incidence was not significantly higher
in the young versus the old STEMI patients. However,
many studies report that non-diabetic AMI patients have
increased blood sugar, compromised glucose tolerance,
and insulin resistance [26,27]. There is a significant cor-
relation between HbA1c level, an indicator of long-term
glycemic control, and the development and prognosis of
coronary diseases; this correlation is less frequently re-
ported in young patients [28]. In our study, STEMI pa-
tients were younger than the peak age of diabetes
incidence, though baseline fasting blood sugar and
HbA1c were significantly higher, suggesting that a higher
proportion of patients had undetected diabetics or pre-
diabetes. As pre-diabetic conditions can influence the
course of STEMI, medical intervention in young people
may help prevent STEMI. The findings of this study
show that whereas fasting blood sugar level is a
dependent risk factor, HbA1c is an independent risk fac-
tor, indicating that HbA1c is more strongly correlated
with STEMI in young people.
Unstable AP before AMI is a clinical manifestation
of ischemic preconditioning; repeated AP prepares the
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function and severe cardiac arrhythmia following AMI
[29]. Klein et al. [30] found that young patients seldom
experience AP before MI, but that AP quickly pro-
gresses to AMI. Consistent with their findings, only
12% of the young STEMI patients in our study experi-
enced AP before STEMI, a significantly smaller per-
centage than in old STEMI patients. STEMI in young
patients generally has no ischemic preconditioning,
and occurs and progresses faster than it does in older
patients. However, troponin I values were similar between
the young and old STEMI groups, and there were no dif-
ferences in the degree of myocardial necrosis.
Study limitations
This study is subject to the usual limitations associated
with a retrospective design. Because of the low incidence
of STEMI in young people, the sample size of this study
was small. Despite adjusting for multiple risk factors, it
is possible that there may have been residual confound-
ing conditions and medications. In addition, no data
were collected about coronary artery disease extension.
Therefore, the influence of some confounders and biases
cannot be completely excluded. Multicenter studies with
large sample sizes will further elucidate the mechanism of
STEMI in the young population. Nevertheless, this study
provides a clinical reference for healthcare professionals to
more fully understand risk factors in young STEMI pa-
tients and to develop early preventative interventions.
Conclusion
In conclusion, STEMI in young people has some clinical
features that are different from those in older patients. In
addition to the conventional risk factors, Fib and HbA1c
are associated with the initiation of STEMI, and can pro-
vide inexpensive and powerful prognostic factors for
STEMI in young patients. STEMI in young patients is
often accompanied by disorders of glucose metabolism and
abnormal coagulation, though AP before STEMI is rare.
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